Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells - Test2 - elhamkhani - TriplyDB

Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells

Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells

http://www.wikidata.org/entity/Q24658237

about

Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism Cellular and molecular biology of small cell lung cancer: an overview Lung cancer biomarkers, targeted therapies and clinical assays Targeting RTK Signaling Pathways in Cancer The roles of fibroblast growth factors in the testicular development and tumor Targeting angiogenesis in squamous non-small cell lung cancer Systemic and targeted therapies for early-stage lung cancer Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers Receptor tyrosine kinases fall into distinct classes based on their inferred signaling networks Image-based compound profiling reveals a dual inhibitor of tyrosine kinase and microtubule polymerization The Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell Lung Cancer: A Meta-Analysis of Published Data Identification of feature genes for smoking-related lung adenocarcinoma based on gene expression profile data Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interaction.The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer.Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression.Combination therapy in combating cancer.Nonamplified FGFR1 is a growth driver in malignant pleural mesothelioma Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo.Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.Knockdown of S100A7 reduces lung squamous cell carcinoma cell growth in vitro and in vivo.Tailoring tyrosine kinase inhibitors to fit the lung cancer genome.Distribution and localization of fibroblast growth factor-8 in rat brain and nerve cells during neural stem/progenitor cell differentiation.Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans.Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells.Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in MET-amplified tumor cells with or without resistance to selective MET Inhibition.Protein kinase C δ is a downstream effector of oncogenic K-ras in lung tumors.Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC.Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.Basic fibroblast growth factor shows prognostic impact on survival in operable non-small cell lung cancer patients

P2860

Q24300524-A5E92BB4-285C-4A2C-B5D0-24C8201771EE Q26767029-EF73A483-DBF9-4842-9EFB-8C81FED5DEC9 Q26775396-C34DD5FC-1678-42C5-85DD-B8591E9D86E6 Q26781278-22FC0B3D-4C49-40EE-8351-B45AC1537E72 Q26823032-63371E0D-DBF6-4B32-9A28-6A6D62B822A1 Q26861341-A3FA53F1-1640-4869-9DED-7FEE5F701113 Q26865490-4B762735-CD62-4502-8DAB-4B1B0A7C2217 Q26998790-B76DB113-3DF2-4548-A3FD-816134A37923 Q26998955-1C180ECD-1A58-4AE7-A2B4-989B1A5B6052 Q27851615-19477D03-885F-4118-85F6-C0A2D7313BE5 Q27851654-D8EFB501-08FD-4CF5-AEF1-43021F93E0A2 Q27852601-2431173C-42A1-45C9-8EEC-70F6C5249446 Q27852999-B796B625-ACBE-4E04-8264-7B99B61794AA Q27853171-4E517CC9-8A60-4919-B289-934FF694E3B3 Q28537891-CEA42D9B-1FC7-4437-B6F4-56EBE9F769BD Q28834113-C65CBD00-CF21-4285-935E-80ADECB75C16 Q31038314-5F3D317B-5005-4027-A450-7D9047856879 Q31150103-0878B157-F153-43F1-B81F-8009EAAF699A Q33165980-7830F7E3-E000-4A85-99D1-DCD6386733EB Q33275125-5A69AFD5-20DC-420A-845C-6FE37BCCD78F Q33399785-358C7703-BBDB-4C64-91B6-9FEBFD126C1A Q33648356-F3B06DC1-94FE-4CDD-82F6-02398D7AFB6B Q33770265-A4F05B22-9952-4CAD-BF25-3CB2A36EF0ED Q33914234-9F227B85-46C0-492D-A143-D64EBD16BB0F Q34364821-2146AAEA-D910-46F0-A9A5-EF0C8B0786EF Q34678587-60FFC3A5-0238-4876-9880-F07F3B780D32 Q34704781-1184BC66-A1EC-41E8-868F-0586FCE16BA5 Q34732996-F8B5CE08-0311-4E12-8BD9-E14C468FEB63 Q34754045-898CD618-E577-4889-87AF-88174E4F9BDA Q35020787-31BA5264-C4DC-4C9F-96F1-78EAF4407459 Q35143027-D6CF1FCD-A47B-4740-8376-B5BF5603788B Q35150612-3E438ACC-877E-4DA5-9323-9CDDC4FDCA47 Q35599107-A2189911-D43A-4470-989F-B5BC69E61A80 Q35688071-118E4C1E-231B-4801-9E9E-D92CA7AD4B90 Q35733900-D903751F-215E-4AF0-937A-F7223457B894 Q35743009-6E0C5AD3-FB69-481A-A734-0A15387FDE38 Q35770299-C6EC46E8-3127-43AF-B3AC-DEB2A11C5FB7 Q35816889-43FE182F-B94C-4F19-8895-7DA05EFFF7FC Q35842078-D47879E6-68CA-404A-84DE-F7958324EC01 Q35879398-FF0E328F-C5B3-4E07-B088-C29AB1B01908

P2860

Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells

http://www.wikidata.org/entity/Q24658237

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Fibroblast growth factor (FGF) ...... n-small-cell lung cancer cells

@ast

Fibroblast growth factor (FGF) ...... n-small-cell lung cancer cells

@en

Fibroblast growth factor (FGF) ...... n-small-cell lung cancer cells

@nl

type

label

Fibroblast growth factor (FGF) ...... n-small-cell lung cancer cells

@ast

Fibroblast growth factor (FGF) ...... n-small-cell lung cancer cells

@en

Fibroblast growth factor (FGF) ...... n-small-cell lung cancer cells

@nl

prefLabel

Fibroblast growth factor (FGF) ...... n-small-cell lung cancer cells

@ast

Fibroblast growth factor (FGF) ...... n-small-cell lung cancer cells

@en

Fibroblast growth factor (FGF) ...... n-small-cell lung cancer cells

@nl

P1433

Q24658237-94A75B21-5DBE-4CB0-B1E7-2D152CFEAA59

P1476

Q24658237-67062434-3124-407B-85A6-5C3F39052C25

P2093

Q24658237-165BEC1B-1C2A-4446-A667-7C069748C903

Q24658237-2AC70A0C-9339-49AC-86E1-670B6EAE0549

Q24658237-32511004-4A45-41D6-8620-97814D8A67F7

Q24658237-38BBC85E-61D4-431D-9D3C-31DD68D03E78

Q24658237-38BDFDB2-49CB-416C-82AA-43C21AA956D0

Q24658237-42309930-FDBA-480D-91A1-6FA1D94F12B9

Q24658237-83418E97-3116-4F07-991D-BC6DE40C6530

Q24658237-938B81E7-75EF-49D1-BC0F-51BA87AC8A03

Q24658237-B105C314-2167-4676-AC8B-A1B0E763275D

Q24658237-C3372C6B-85AD-4C45-86D0-307495736E05

P2860

Q24658237-02A021DF-7743-47E6-843F-7866F9C063FF

Q24658237-078EDDD8-AA8E-489D-85C3-CA961CABC4E0

Q24658237-0EDB7CCF-F2FE-48A7-8803-3207660D2B2D

Q24658237-1848D004-48B5-40C2-A626-EAD353B8A446

Q24658237-19871BD4-69C2-4547-86DA-0907DD9887A3

Q24658237-1EB207F3-BCCA-4836-8EEF-553041CA489E

Q24658237-2FBF608D-E4E6-4541-A4DF-F3402CEFBE5D

Q24658237-308E76FF-A927-4E22-BCD9-85550C9BA49A

Q24658237-35F5E270-F372-4EAC-8BD7-8FB12D76E39D

Q24658237-39D08AC9-FE1C-4974-9BA4-882D6B6E3E11

P304

Q24658237-4937C7A0-46E8-4B07-B068-942D00A93809

P31

Q24658237-721DFC2F-EE73-4770-A261-5C959E50CF7C

P3181

Q24658237-4A4CF6D6-0DD1-4010-8CCA-F93ECAA98C8C

P356

Q24658237-254B5B06-72C1-4103-8D07-E235B7BCD943

P407

Q24658237-60FA1F1E-CE15-406F-BE21-4575E457527C

P433

Q24658237-01AD1782-5F5D-4438-ADF2-C7612A0D033C

P478

Q24658237-FD64C81B-051C-43CF-9902-4187091EB850

P577

Q24658237-E199F6ED-86B9-443C-84CB-5F963F86B904

P5875

Q24658237-408285A0-5FD0-4B22-BDF5-577F70F77D70

P698

Q24658237-EB616218-1135-4664-A272-5B32F91EC8A5

P932

Q24658237-A5765E05-E3D6-4948-A1FF-CDB41EBE37D3

P3181

P356

P1433

Molecular Pharmacology

P1476

Fibroblast growth factor (FGF) ...... n-small-cell lung cancer cells

@en

P2093

Alexa Fritzsche

http://www.w3.org/2001/XMLSchema#string

Barbara A Helfrich

http://www.w3.org/2001/XMLSchema#string

Christopher D Coldren

http://www.w3.org/2001/XMLSchema#string

Daniel T Merrick

http://www.w3.org/2001/XMLSchema#string

Jennifer E Smith

http://www.w3.org/2001/XMLSchema#string

Kathryn E Ware

http://www.w3.org/2001/XMLSchema#string

Lee A McDermott

http://www.w3.org/2001/XMLSchema#string

Lindsay Marek

http://www.w3.org/2001/XMLSchema#string

Lynn E Heasley

http://www.w3.org/2001/XMLSchema#string

Paul A Bunn

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Cellular signaling by fibroblast growth factor receptors

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies

Alternative splicing of fibroblast growth factor receptors in human prostate cancer.

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers.

P304

196-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2061378

http://www.w3.org/2001/XMLSchema#string

P356

10.1124/MOL.108.049544

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23312055

http://www.w3.org/2001/XMLSchema#string

P698

18849352

http://www.w3.org/2001/XMLSchema#string

P932

2669785

http://www.w3.org/2001/XMLSchema#string